🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalJapan GLP-1 access — navigating the Japanese healthcare system Page 2

Japan GLP-1 access — navigating the Japanese healthcare system

mark_tokyo Thu, Jun 4, 2026 at 1:04 AM 8 replies 277 viewsPage 2 of 2
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Jun 4, 2026 at 4:53 AM#6

The figures, for anyone assembling their own picture. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Last edited: Jun 4, 2026 at 8:53 AM
45 15sarah_nash92, FitDadDave, RunnerRach and 42 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Jun 4, 2026 at 6:22 AM#7

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

44 14BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 41 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jun 4, 2026 at 7:51 AM#8
bri_stats said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Coming at bri_stats’s question from a different direction. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

43 13josh_phd_bmore, roxy_nash, tony_orlando and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Jun 4, 2026 at 9:20 AM#9

Closing the loop on my own question.

Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.

Last edited: Jun 4, 2026 at 12:20 PM
42 12HPLC_Greg, LibrarianMeg, bri_stats and 39 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Jun 4, 2026 at 4:26 PM#10
BariatricNurseD said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

That is correct as far as it goes, and here is where it stops going. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

26 1TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 23 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register